Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of CAM-3001 in rheumatoid arthritis has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CAM-3001

Snippet

Sponsor: MedImmune LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2017-02-16